Physician profile
Jaimin Amin
NPI 1588955066
$5,907.25
in general payments reported to CMS, 2019-2025
28 companies · $2,082 in 2025
The $2,082 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $222 · 2021: $309 · 2022: $773 · 2023: $1,099 · 2024: $835 · 2025: $2,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713 · Travel and Lodging: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.90 |
| Travel and Lodging | $1,301.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,504.50 | 2019-2025 | Exalt Model D, Spyglass, Spyglass |
| Olympus Corporation of The Americas | $1,367.31 | 2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Medtronic, INC. | $384.34 | 2021-2023 | Prodigi |
| Endogastric Solutions, INC | $323.05 | 2022-2024 | Esophyx |
| Covidien Lp | $302.84 | 2019-2020 | |
| Apollo Endosurgery US INC | $257.77 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Cook Medical LLC | $250.90 | 2019-2023 | Hemospray |
| Conmed Corporation | $230.97 | 2019-2025 | Conmed Biliary, Conmed Hemostasis, Conmed Generators |
| Abbvie INC. | $212.79 | 2022-2025 | Skyrizi |
| Erbe USA INC | $192.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.45 | 2022-2025 | Xifaxan |
| Madrigal Pharmaceuticals | $147.23 | 2025 | Rezdiffra |
| Qol Medical, LLC | $79.21 | 2024-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $67.18 | 2024-2025 | Tremfya, Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $58.11 | 2023-2024 | Entyvio, Eohilia |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $56.60 | 2025 | |
| Lilly USA, LLC | $44.08 | 2023-2024 | Omvoh |
| Phathom Pharmaceuticals, INC. | $42.11 | 2024-2025 | Voquezna |
| Ambu INC. | $40.99 | 2022 | |
| Echosens North America, INC. | $30.55 | 2024 | Fibroscan |
| Ardelyx, INC. | $30.26 | 2024 | Ibsrela |
| Braintree Laboratories, INC. | $22.36 | 2023 | Suflave, Sutab |
| Regeneron Healthcare Solutions, INC. | $18.93 | 2024 | Dupixent |
| Exact Sciences Corporation | $17.79 | 2023 | Cologuard Collection Kit |
| Ipsen Biopharmaceuticals, INC | $17.42 | 2024 | |
| Pfizer INC. | $14.72 | 2023 | |
| Ironwood Pharmaceuticals, INC | $13.40 | 2024 | |
| Merit Medical Systems INC | $13.19 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaimin Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.